Accumulation of boron compounds to tumor with polyethylene-glycol binding liposome by using neutron capture autoradiography
- PMID: 15246411
- DOI: 10.1016/j.apradiso.2004.03.109
Accumulation of boron compounds to tumor with polyethylene-glycol binding liposome by using neutron capture autoradiography
Abstract
The cytotoxic effect of boron neutron capture therapy (BNCT) is due to a nuclear reaction between 10B and thermal neutrons. It is necessary to accumulate the 10B atoms to the tumor cells selectively for effective BNCT. In order to achieve an accurate measurement of 10B concentrations in the biological samples, we employed a technique of neutron capture autoradiography (NCAR) of the sliced whole-body samples of tumor bearing mice using CR-39 plastic track detectors. The CR-39 detectors attached with samples were exposed to thermal neutrons in the thermal column of the TRIGA II reactor at the Institute for Atomic Energy, Rikkyo University and thermal neutron facility of Paul Scherer Institute(PSI). We obtained NCAR images for mice injected intravenously by 10B-PEG liposome, 10B-transferrin-PEG liposome, or 10B-bare liposome. The 10B concentrations in the tumor tissue of mice were estimated by means of alpha-track density measurements. In this study, we can increase the accumulation of 10B atoms in the tumor tissues by binding polyethylene-glycol chains to the surface of liposome, which increase the retention in the blood flow and escape the phagocytosis by reticulo-endothelial systems. Therefore, we will be able to apply NCAR technique for selection of effective 10B carrier in BNCT for cancer.
Similar articles
-
Neutron capture autoradiographic study of the biodistribution of 10B in tumor-bearing mice.Appl Radiat Isot. 2004 Oct;61(4):585-90. doi: 10.1016/j.apradiso.2004.03.084. Appl Radiat Isot. 2004. PMID: 15246403
-
Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).J Control Release. 2004 Aug 11;98(2):195-207. doi: 10.1016/j.jconrel.2004.04.018. J Control Release. 2004. PMID: 15262412
-
Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.Biomed Pharmacother. 2006 Jan;60(1):43-50. doi: 10.1016/j.biopha.2005.05.011. Epub 2005 Sep 21. Biomed Pharmacother. 2006. PMID: 16260113
-
Boron neutron capture therapy of brain tumors: past history, current status, and future potential.Cancer Invest. 1996;14(6):534-50. doi: 10.3109/07357909609076899. Cancer Invest. 1996. PMID: 8951358 Review.
-
[Minimally invasive cytoselective radiation therapy using boron neutron capture reaction].Yakugaku Zasshi. 2010 Dec;130(12):1687-94. doi: 10.1248/yakushi.130.1687. Yakugaku Zasshi. 2010. PMID: 21139396 Review. Japanese.
Cited by
-
Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy.Br J Radiol. 2017 Jun;90(1074):20170004. doi: 10.1259/bjr.20170004. Epub 2017 May 25. Br J Radiol. 2017. PMID: 28406315 Free PMC article.
-
Use of the Highly Biocompatible Au Nanocages@PEG Nanoparticles as a New Contrast Agent for In Vivo Computed Tomography Scan Imaging.Nanoscale Res Lett. 2020 Mar 4;15(1):53. doi: 10.1186/s11671-020-3286-2. Nanoscale Res Lett. 2020. PMID: 32130549 Free PMC article.
-
Antitumour effect of polyoxomolybdates: induction of apoptotic cell death and autophagy in in vitro and in vivo models.Br J Cancer. 2008 Jan 29;98(2):399-409. doi: 10.1038/sj.bjc.6604133. Epub 2007 Dec 18. Br J Cancer. 2008. PMID: 18087283 Free PMC article.
-
Suppression of Tumor Growth in a Rabbit Hepatic Cancer Model by Boron Neutron Capture Therapy With Liposomal Boron Delivery Systems.In Vivo. 2021 Nov-Dec;35(6):3125-3135. doi: 10.21873/invivo.12607. In Vivo. 2021. PMID: 34697143 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources